C.G. Evans, PhD | Authors

Articles

MiR-34a Link to PD-L1 May Mean New Immunotherapy in NSCLC

May 14, 2015

Two presentations at this year’s American Association for Cancer Research (AACR) annual meeting linked a specific microRNA (miRNA), miR-34a, to an active area in immunotherapy, programed cell death-1 (PD-1) protein and its ligand, PD-L1.